Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing etanercept (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing trastuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trastuzumab 150 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Murine-human monoclonal IgG antibody (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etanercept 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etanercept 25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trastuzumab 440 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Infliximab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing alemtuzumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alemtuzumab 30mg/3mL infusion concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alemtuzumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Palivizumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Abciximab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Daclizumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Basiliximab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trastuzumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etanercept (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetuximab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Arcitumomab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natalizumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ofatumumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipilimumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rituximab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vedolizumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gemtuzumab ozogamicin (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Omalizumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Muromonab-CD3 (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Secukinumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Efalizumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Inolimomab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trastuzumab emtansine |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risankizumab |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Crizanlizumab (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trastuzumab deruxtecan (substance) |
Is a |
False |
anticorps monoclonal chimérique souris-humain d'isotype IgG |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|